Skip to main content
Top
Published in: Inflammation Research 1/2011

01-01-2011 | Original Research Paper

Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese

Authors: Bangqiong Wang, Qifu Li, Yuanjuan Jiang, Zhoujun Liu, Li Zhong, Rong Luo, Qingfeng Cheng, Hua Qing

Published in: Inflammation Research | Issue 1/2011

Login to get access

Abstract

Objective

To compare association of complement C3 (C3) and high sensitive C-reactive protein (hs-CRP) with insulin resistance.

Subjects

A total of 587 non-diabetic Chinese aged 20–80 years were recruited.

Methods

Complement C3 and hs-CRP were measured by the rate nephelometry method and the particle enhanced immunoturbidimetric method, respectively, and their relationship to insulin resistance was assessed. Insulin resistance was defined as the upper quartile of HOMA2-IR.

Results

Complement C3 and hs-CRP were significantly higher in subjects with insulin resistance than those without. Complement C3 was the second strongest determinant of insulin in the study (β = 0.34, P < 0.001). By regression analysis, C3 was significantly associated with insulin resistance (OR = 3.78, P < 0.05), independent of waist circumference and other metabolic risk factors; however, hs-CRP was not. Receiver operating characteristic curve analysis indicated the best model predicting insulin resistance was one that included C3 and waist circumference (AUC = 0.741, P < 0.05).

Conclusion

Compared to hs-CRP, serum C3 might be a better inflammatory marker of insulin resistance in the non-diabetic Chinese population.
Literature
1.
go back to reference Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol. 2002;20:538–44. Pyorala M, Miettinen H, Halonen P, Laakso M, Pyorala K. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol. 2002;20:538–44.
2.
go back to reference Lee W, Park J, Noh S, Rhee E, Sung K, Kim B, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol. 2004;97:101–6.CrossRefPubMed Lee W, Park J, Noh S, Rhee E, Sung K, Kim B, et al. C-reactive protein concentrations are related to insulin resistance and metabolic syndrome as defined by the ATP III report. Int J Cardiol. 2004;97:101–6.CrossRefPubMed
3.
go back to reference Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4–7.CrossRefPubMed Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4–7.CrossRefPubMed
4.
go back to reference Muscari A, Antonelli S, Bianchi G, Cavrini G, Dapporto S, Ligabue A, et al. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate. Diabetes Care. 2007;30:2362–8.CrossRefPubMed Muscari A, Antonelli S, Bianchi G, Cavrini G, Dapporto S, Ligabue A, et al. Serum C3 is a stronger inflammatory marker of insulin resistance than C-reactive protein, leukocyte count, and erythrocyte sedimentation rate. Diabetes Care. 2007;30:2362–8.CrossRefPubMed
5.
go back to reference Pischon T, Hu F, Rexrode K, Girman C, Manson J, Rimm E. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis. 2008;197:392–9.CrossRefPubMed Pischon T, Hu F, Rexrode K, Girman C, Manson J, Rimm E. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men. Atherosclerosis. 2008;197:392–9.CrossRefPubMed
6.
go back to reference Koenig W, Khuseyinova N, Baumert J, Meisinger C. Prospective study of high sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984–1998. Clin Chem. 2008;54:335–42.CrossRefPubMed Koenig W, Khuseyinova N, Baumert J, Meisinger C. Prospective study of high sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984–1998. Clin Chem. 2008;54:335–42.CrossRefPubMed
7.
go back to reference Ridker P, Glynn R, Hennekens C. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007–11.PubMed Ridker P, Glynn R, Hennekens C. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007–11.PubMed
8.
go back to reference Yudkin J, Juhan-Vague I, Hawe E, Humphries S, di Minno G, Margaglione M, et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism. 2004;53:852–7.CrossRefPubMed Yudkin J, Juhan-Vague I, Hawe E, Humphries S, di Minno G, Margaglione M, et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism. 2004;53:852–7.CrossRefPubMed
9.
go back to reference Barnum S, Volanakis J. Structure and function of C3. Year Immunol. 1989;6:208–28.PubMed Barnum S, Volanakis J. Structure and function of C3. Year Immunol. 1989;6:208–28.PubMed
10.
go back to reference Scantlebury T, Sniderman A, Cianflone K. Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochem Genet. 2001;356:445–52. Scantlebury T, Sniderman A, Cianflone K. Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochem Genet. 2001;356:445–52.
11.
go back to reference Meijssen S, van Dijk H, Verseyden C, Erkelens D, Cabezas M. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2002;22:811–6.CrossRefPubMed Meijssen S, van Dijk H, Verseyden C, Erkelens D, Cabezas M. Delayed and exaggerated postprandial complement component 3 response in familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol. 2002;22:811–6.CrossRefPubMed
12.
go back to reference Hernández-Mijares A, Jarabo-Bueno M, López-Ruiz A, Solá-Izquierdo E, Morillas-Ariño C, Martínez-Triguero M. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obes. 2007;31:927–32.CrossRef Hernández-Mijares A, Jarabo-Bueno M, López-Ruiz A, Solá-Izquierdo E, Morillas-Ariño C, Martínez-Triguero M. Levels of C3 in patients with severe, morbid and extreme obesity: its relationship to insulin resistance and different cardiovascular risk factors. Int J Obes. 2007;31:927–32.CrossRef
13.
go back to reference Mantov S, Raev D. Additive effects of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis. Int J Cardiol. 1996;56:145–8.CrossRefPubMed Mantov S, Raev D. Additive effects of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis. Int J Cardiol. 1996;56:145–8.CrossRefPubMed
14.
go back to reference Engström G, Hedblad B, Eriksson K, Janzon L, Lindgärde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes Care. 2005;54:570–5. Engström G, Hedblad B, Eriksson K, Janzon L, Lindgärde F. Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes Care. 2005;54:570–5.
15.
go back to reference Szeplaki G, Prohaszka Z, Duba J, Rugonfalvi Kiss S, Karadi I, Kokai M, et al. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis. 2004;177:383–9.CrossRefPubMed Szeplaki G, Prohaszka Z, Duba J, Rugonfalvi Kiss S, Karadi I, Kokai M, et al. Association of high serum concentration of the third component of complement (C3) with pre-existing severe coronary artery disease and new vascular events in women. Atherosclerosis. 2004;177:383–9.CrossRefPubMed
16.
go back to reference Carter A, Prasad U, Grant P. Complement C3 and C-reactive protein in male survivors of myocardial infarction. Grant Atheroscler. 2009;203:538–43.CrossRef Carter A, Prasad U, Grant P. Complement C3 and C-reactive protein in male survivors of myocardial infarction. Grant Atheroscler. 2009;203:538–43.CrossRef
17.
go back to reference World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. World Health Organisation, Geneva World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. Part 1: diagnosis and classification of diabetes mellitus. World Health Organisation, Geneva
18.
go back to reference Williams B, Poulter N, Brown M, Davis M, Mclnnes G, Potter J, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004;328:634–40.CrossRefPubMed Williams B, Poulter N, Brown M, Davis M, Mclnnes G, Potter J, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ. 2004;328:634–40.CrossRefPubMed
19.
go back to reference Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed
20.
go back to reference Wannamethee S, Lowe G, Shaper A, Rumley A, Lennon L, Whincup P. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis. 2005;181:101–8.CrossRefPubMed Wannamethee S, Lowe G, Shaper A, Rumley A, Lennon L, Whincup P. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-diabetic men. Atherosclerosis. 2005;181:101–8.CrossRefPubMed
21.
go back to reference Eklund C. Proinflammatory cytokines in CRP baseline regulation. Advances in clinical chemistry. Adv Clin Chem. 2009;48:111–36.CrossRefPubMed Eklund C. Proinflammatory cytokines in CRP baseline regulation. Advances in clinical chemistry. Adv Clin Chem. 2009;48:111–36.CrossRefPubMed
22.
go back to reference Steppan C, Lazar M. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;13:18–23.CrossRefPubMed Steppan C, Lazar M. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab. 2002;13:18–23.CrossRefPubMed
23.
go back to reference Halkes C, van Dijk H, de Jaegere P, Plokker H, van der Helm Y, Erkelens D, et al. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol. 2001;21:1526–30.CrossRefPubMed Halkes C, van Dijk H, de Jaegere P, Plokker H, van der Helm Y, Erkelens D, et al. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol. 2001;21:1526–30.CrossRefPubMed
24.
go back to reference Donahue R, Bean J, Donahue R, Goldberg R, Prineas R. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami community health study. Arterioscler Thromb Vasc Biol. 1997;17:2413–7.PubMed Donahue R, Bean J, Donahue R, Goldberg R, Prineas R. Does insulin resistance unite the separate components of the insulin resistance syndrome? Evidence from the Miami community health study. Arterioscler Thromb Vasc Biol. 1997;17:2413–7.PubMed
25.
go back to reference Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Drago G, et al. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J. 2000;21:1081–90.CrossRefPubMed Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Drago G, et al. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J. 2000;21:1081–90.CrossRefPubMed
26.
go back to reference Weyer C, Tataranni P, Pratley R. Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care. 2000;23:779–85.CrossRefPubMed Weyer C, Tataranni P, Pratley R. Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care. 2000;23:779–85.CrossRefPubMed
Metadata
Title
Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese
Authors
Bangqiong Wang
Qifu Li
Yuanjuan Jiang
Zhoujun Liu
Li Zhong
Rong Luo
Qingfeng Cheng
Hua Qing
Publication date
01-01-2011
Publisher
SP Birkhäuser Verlag Basel
Published in
Inflammation Research / Issue 1/2011
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-010-0236-y

Other articles of this Issue 1/2011

Inflammation Research 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.